Gary M. Franklin, MD, MPH

Research Professor, Env. and Occ. Health Sciences (Primary department)
Adjunct Research Professor, Health Services
Dr. Gary M. Franklin obtained the MD degree from George Washington University, and the MPH degree from the University of California at Berkeley. He is a board-certified neurologist whose current positions are Research Professor, Department of Environmental and Occupational Health Sciences Medicine (Neurology) and Health Services, University of Washington, and Medical Director, Washington State Department of Labor and Industries. His major research interests include use of administrative databases (workers' compensation) to conduct epidemiologic research, outcome of medical treatment modalities for occupational musculoskeletal disease, predictors of disability in workers' compensation, and impact of innovative care delivery systems on cost, outcome and satisfaction in workers' compensation. Dr. Franklin also has interests in occupational and environmental neurology, including cumulative trauma disorders, and assessing impairment and disability of occupational and environmental diseases.

Contact Information

Box: 359116
University of Washington
Seattle, WA 98109-
Tel: 206-685-7193
Fax: 206-685-7031

Research Interests

  • Occupational injury, neurological epidemiology, outcomes research
  • KEYWORDS: Occupational and environmental medicine; Occupational disease statistics; Occupational and environmental epidemiology; Occupational exposure; Opiate use; Surveillance of occupational illnesses and injuries; Workers' compensation issues

Education

MD, Internal Medicine, George Washington University, 1969
MPH, Pub Health & Comm Med, University of California (Berkeley), 1982

Projects

1. Outcomes Tracking Project

Investigators: Gary Franklin, Tom Wickizer, Judy Turner, Deborah Fulton-Kehoe, Terri Smith-Weller The goals of this project are to develop systems to track outcomes, satisfaction, and quality of care in the medical treatment of injured workers to be used as an information base for quality improvement activities. General methods will be developed to identify opportunities to improve treatment or care delivery. Specific methods will be developed to evaluate the pilot Centers of Occupational Health and Education. This project will identify appropriate measures of satisfaction, quality of care, and treatment outcome; assess the feasibility of systematically collecting outcome data in a workers' compensation environment; and develop and implement a pilot test of these methods.

2. Evaluation of Diagnostic Accuracy of Magnetic Resonance Imaging in Patients with Suspected Carpal Tunnel Syndrome

Investigators: Jeffrey Jarvik, Gary Franklin, Terri Smith-Weller, Cynthia Bradley, Deborah Fulton-Kehoe This project was partially funded by the Royalty Research Fund. We are evaluating the sensitivity, specificity, and predictive value of MR for the diagnosis of carpal tunnel syndrome compared with electrodiagnostic and clinical information. Subjects were recruited from Harborview, the VA, and University Hospital. The first phase of this study was completed in June 1998. One year follow-up of the initial patients has been completed.

3. Occupational Carpal Tunnel in Washington State, 1984 to 1995

Investigators: Bill Daniell, Gary Franklin, Deborah Fulton-Kehoe This is a population-based incidence study of occupational carpal tunnel syndrome. This study will examine the incidence of CTS by gender, age, industrial background, and time. The cost associated with CTS, including medical, time loss, and permanent disability will be calculated. The preliminary results will be used to plan a prospective study of the clinical management of CTS.

4. Pain Center Outcome Study

Investigators: Jim Robinson, Deborah Fulton-Kehoe, Gary Franklin We have identified all patients treated at pain centers over two years and compared them to a similar group of patients that was evaluated but not treated at pain centers. Analysis of predictors of acceptance for treatment and of predictors of time loss status has been completed. The survey of patients has been completed. A manuscript has been submitted to the American Journal of Industrial Medicine.

5. Literature Review of Pain Center Efficacy and Prognostic Factors

Investigators: Jim Robinson, Deborah Fulton-Kehoe, Gary Franklin, Cynthia Bradley We are conducting a thorough review of the pain center literature, focusing on prognostic factors. We have completed a Medline search, selected relevant titles, and screened articles for inclusion criteria. We are currently reviewing articles and summarizing results.

6. Prospective Study of Predictors of Long-Term Disability

Investigators: Gary Franklin, Deborah Fulton-Kehoe, Terri Smith-Weller, Judy Turner, Tom Wickizer, and additional consultants We are submitting a grant application for a large prospective study to determine predictors of disability.

Selected Publications

ORIGINAL ARTICLES

  1. Panitch HS and Franklin GM. Elevation of serum creatine phosphokinase in amyotrophic lateral sclerosis. Neurology 22:964, 1972.
  2. Diamond I, Franklin GM, Milfay D. The relationship of choline acetyltransferase activity at the neuromuscular junction to changes in muscle mass and function. J Physiol. 236:247-257, 1974.
  3. Franklin GM, Dudzinski DS, Culter RWP. Amino acid transport into the cerebrospinal fluid of the rat. J Neurochem. 24:367-372, 1975.
  4. Franklin GM, Neilson KD, Diehl J. Cranial pneumatocele — a clue into the diagnosis of occult epidural abscess. Arch Neurol 33:272-273, 1976.
  5. Berg TO, Franklin GM, Cuneo RA, Boldrey EE, Strimling BS. Non-surgical cure of cerebral abscess:  Early diagnosis and follow-up with computerized tomography. Annals Neurol 3(6): 474-478, 1978.
  6. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapsing/remitting and chronic/progressive multiple sclerosis. J Consul Clin Psychol 53:103-110, 1985.
  7. Thompson DS, Nelson LM, Burns A, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis:  A retrospective study. Neurology 36:1097-1099, 1986.
  8. Nelson LM, Hamman RF, Thompson DS, Baum H, Burks JS, Franklin GM. Higher than expected prevalence of multiple sclerosis (MS) in Northern Colorado. Neuroepidemiology 5:17-28, 1986.
  9. Franklin GM, Ringel SP, Nelson LM, DeLapp HC. Neurology practice patterns in Colorado. Neurology 37:287-289, 1987.
  10. Nelson LM, Franklin GM, Hamman RF, Boteler DL, Baum HM, Burks JS. Referral bias in multiple sclerosis research. J Clin Epidemiol 41:187-1992, 1988.
  11. Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS. Stress and its relationship to acute exacerbations in multiple sclerosis (MS). J Neurol Rehab 2:7-11, 1988.
  12. Nelson LM, Franklin GM, Jones MC, the MS Study Group. Risk of multiple sclerosis exacerbation during pregnancy and breastfeeding. JAMA 259:3441-3443, 1988.
  13. Ringel SP, Franklin GM, DeLapp HC, Boyko E. A cross-sectional comparative study of outpatient neurologic practices in Colorado. Neurology 38:1308-1314, 1988.
  14. Franklin GM, Heaton RK, Filley CM, Seibert CE, Nelson LM. Correlation of neuropsychological and magnetic resonance imaging (MRI) findings in chronic/progressive multiple sclerosis. Neurology 38:1826-1829, 1988.
  15. Filley CM, Franklin GM, Heaton RK, Rosenberg NL. White matter dementia:  Clinical disorders and implications. Neuropsychiat Neuropsychol Behav Neurol 1:239-254, 1988.
  16. Franklin GM, Nelson LM, Filley CM, Heaton RK. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol 46:157-161, 1989.
  17. Franklin GM, Nelson LM, Filley CM, Heaton RK. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Arch Neurol 46:162-167, 1989.
  18. Robertson RP, Franklin GM, Nelson LM, Intravenous glucose tolerance and pancreatic islet beta cell function in patients with multiple sclerosis during two years' treatment with cyclosporine. Diabetes 38:58-64, 1989.
  19. Cohen JA, Hossack K, Franklin GM. Multiple sclerosis patients with fatigue:  relationship among temperature regulation, autonomic dysfunction, and exercise capacity. J Neurol Rehab 3:193-198, 1989.
  20. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin dependent diabetes mellitus:  The San Luis Valley Diabetes Study. Am J Epidemiol 131:633-43, 1990.
  21. Franklin GM, Ringel SP, Jones M, DeLapp C. A prospective study of principal care among Colorado neurologists. Neurology 40:701-4, 1990.
  22. The Multiple Sclerosis Study Group. Efficacy and toxicity of cyclosporine in chronic-progressive multiple sclerosis:  A randomized double-blind placebo-controlled clinical trial. Ann Neurol 27:591-605, 1990.
  23. Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM, Nelson LM, Hauser SL. Multiple sclerosis sibling pairs:  Clustered onset and familial predisposition. Neurology 40:1546-1552, 1990.
  24. Brar SP, Smith MB, Nelson LM, Franklin GM, Cobble NP. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis. Arch Phys Med Rehab 72:186-189, 1991.
  25. Franklin GM, Haug J, Heyer N, Peck N, Checkoway H. Occupational carpal tunnel syndrome incidence in Washington State, 1984-1988. Am J Public Health 81:741-746, 1991.
  26. Hamman RF, Franklin GM, Mayer EJ, Marshall SM, Marshall JA, Baxter J, Kahn LB. Microvascular complications of non-insulin dependent diabetes mellitus (NIDDM) in Hispanics and non-Hispanic whites. San Luis Valley Diabetes Study. Diabetes Care 14:655-664, 1991.
  27. Wechsler LS, Checkoway H, Franklin GM, Costa LG. A pilot study of occupational and environmental risk factors for Parkinson's disease. Neurotoxicology 12:387-392, 1991.
  28. Smith MB, Brar SP, Nelson LM, Franklin GM, Cobble ND. Baclofen effect on quadriceps strength in multiple sclerosis. Arch Phys Med Rehabil 73:237-240, 1992.
  29. Heyer NJ, Franklin GM, Rivara FP, Parker JD, Haug JA. Occupational injuries among minors doing farm work in Washington State:  1986-1989. Am J Public Health 82:557-560, 1992.
  30. Cheadle A, Franklin GM, Wolfhagen C, et al. Factors influencing duration of work-related disability: A population-based study from Washington State Workers’ Compensation. Am J Public Health 84:190-196, 1994.
  31. Adams ML, Franklin GM, Barnhart S. Outcome of carpal tunnel surgery in Washington workers’ compensation. Am J Ind Med 25:527-536, 1994.
  32. Alexander BH, Franklin GM, Wolfe ME. Sexual Assault of women at work in Washington State, 1980-1989. Am J Public Health 84:640-642, 1994.
  33. Heyer NJ, Franklin GM. Work-related traumatic brain injury in Washington State, 1988 through 1990. Am J Public Health 84:1106-1109, 1994.
  34. Franklin GM, Haug JA, Heyer NJ, McKeefrey SP, Picciano J. Outcome of lumbar fusion in Washington State workers’ compensation. Spine 19:1897-1904, 1994.
  35. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in non-insulin dependent diabetes mellitus (NIDDM): The San Luis Valley Diabetes Study. Diabetes Care 17:1172-1177, 1994.
  36. Kushleika J, Checkoway H, Woods JS, Moon J-D, Smith-Weller T, Franklin GM, Swanson PD. Selegiline and lymphocyte superoxide dismutase activities in Parkinson’s Disease. Ann Neurol 39:378-381, 1996.
  37. Franklin GM, Fulton-Kehoe D. Outcomes research in Washington state workers’ compensation. Am J Ind Med 29:642–648, 1996.
  38. Silverstein M, Silverstein B, Franklin GM. Evidence for work-related musculoskeletal disorders: A scientific counterargument. J Occup Environ Med 38:477–484, 1996.
  39. Kyes KB, Franklin GM, Weaver MR. Reliability and validity of medical outcome and patient satisfaction measures among injured workers in Washington State: A pretest. Am J Ind Med 31:427-434, 1997.
  40. Daniell WE, Stockbridge HL, Labbe RF, Woods JS, Anderson KE, Bissell DM, Bloomer JR, Ellefson RD, Moore MR, Pierach CA, Schreiber WE, Tefferri A, Franklin GM. Environmental chemical exposures and disturbances of heme synthesis. Environ Health Perspect 105(Suppl 1):37-53, 1997.
  41. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, and Costa LG. Association of a polymorphism in Intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genetics 74:154-156, 1997.
  42. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Study. Diabetes Care 20: 1997.
  43. Elam K, Taylor V, Ciol MA, Franklin GM, Deyo RA. Medical treatment guidelines and review criteria: Impact of a practice guideline on lumbar fusion rate in Washington State Workers’ Compensation. Medical Care 35:417-424, 1997.
  44. Thiamine deficiency in TPN causes lactic acidosis. Reported by: Silverman B, Franklin GM, Bolin R, Zeller WP, Hensrud DD. American Society for Parenteral and Enteral Nutrition, National Center for Infectious Diseases, CDC. MMWR 46:523-528, 1997.
  45. Teschke K, Morgan MS, Checkoway H, Franklin G, Spinelli JJ, van Belle G, Weiss N. Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens. Occup & Environ Med 54:443-451, 1997.
  46. Teschke K, Morgan MS, Checkoway H, Franklin G, Spinelli JJ, van Belle G, Weiss NS. Mesothelioma surveillance to locate sources of exposure to asbestos. Can J Publ Health 88:163-168, 1997.
  47. Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG. A genetic polymporphism of MAO-B modifies the association of cigarette smoking and Parkinson’s disease. Neurology 50:1458-1461, 1998.
  48. Daniell WE, Fulton-Kehoe D, Smith-Weller T, Franklin GM. Occupational hearing loss in Washington State, 1984-91: I. Statewide and industry-specific incidence. Am J Ind Med 33:519-528, 1998.
  49. Daniell WE, Fulton-Kehoe D, Smith-Weller T, Franklin GM. Occupational hearing loss in Washington State, 1984-91: II. Morbidity and associated costs. Am J Ind Med 33:529-536, 1998.
  50. Franklin GM, Lifka J, Milstein JD. Device evaluation and coverage policy in workers’ compensation: examples from Washington state. Am J Managed Care 4:SP178-186, 1998.
  51. Ramsey SD, Luce BR, Deyo R, Franklin GM. The limited state of technology assessment for medical devices: facing the issues. Am J Managed Care 4:SP188-199, 1998.
  52. Pollack ES, Franklin GM, Fulton-Kehoe D, Chowdhury R. Risk of job-related injury among construction laborers with a diagnosis of substance abuse. J Occup Environ Med 40:573-577, 1998.
  53. Rempel D, Evanoff B, Amadio PC, deKrom M, Franklin G, Franzblau A, Gray R, Gerr F, Hagberg M, Hales T, Katz JM, Pransky G. Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health 88:1447-1451, 1998.
  54. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in parkinsons disease: the role of food groups and specific foods. Movement Disorders 14:21-27, 1999.
  55. Kyes KB, Wickizer T, Franklin G, Cain K, Cheadle A, Madden C, Murphy L, Plaeger-Brockway R, Weaver M. Evaluation of the Washington State workers’ compensation managed care pilot I: Medical outcomes and patient satisfaction. Med Care 37:972-981, 1999.
  56. Cheadle A, Wickizer TM, Franklin G, Cain K, Joesch J, Kyes K, Madden C, Murphy L, Plaeger-Brockway R, Weaver M. Evaluation of the Washington State workers’ compensation managed care pilot project II: Medical and disability costs. Med Care 37:982-993, 1999.
  57. Alexander BH, Franklin GM, Fulton-Kehoe D. A comparison of fatal and severe nonfatal traumatic work-related injuries in Washington State. Am J Ind Med 36:317-325, 1999.
  58. Wickizer TM, Lessler D, Franklin G. Controlling workers’ compensation medical care use and costs through utilization management. J Occup Environ Med 41:625-631, 1999.
  59. Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson’s disease and does not modify the effect of smoking on Parkinson’s disease. Neurosci Lett 278:33-36, 2000.
  60. Fulton-Kehoe D, Franklin G, Weaver M, Cheadle A. Years of productivity lost among injured workers in Washington State: Modeling disability burden in workers’ compensation. Am J Ind Med 37:656-662, 2000.
  61. Franklin GM, Fulton-Kehoe D, Bradley C, Smith-Weller T. Outcome of thoracic outlet surgery in Washington State workers’ compensation. Neurology 54:1252-1257, 2000.
  62. Kissel JT, Franklin GM, and the Quality Standards Subcommittee of the American Academy of Neurology. Treatment of myasthenia gravis. A call to arms (Editorial). Neurology 55:3-4, 2000.
  63. Kirchner SC, Farin FM, Dilley J, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson’s disease. Neurotoxicology 21:441-445, 2000.
  64. Costa-Mallen, P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Genetic polymorphism of dopamine D2 receptors in Parkinson’s disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry 69:535-537, 2000.
  65. Turner JA, Franklin G, Turk, DC. Predictors of chronic disability in injured workers: a systematic literature synthesis Am J Ind. Med 38:707-722, 2000.
  66. Robinson JP, Fulton-Kehoe D, Martin DC, Franklin GM. Outcomes of pain center treatment in Washington State workers’ compensation. Am J Ind. Med 39:227-236, 2001.
  67. Farin FM, Hitosis Y, Hallagan SE, Kushleika J, Woods JS, Janssen PS, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Genetic polymorphisms of superoxide dismutase in Parkinson’s disease. Mov Disord 2001 16:705-707, 2001.
  68. Wickizer, TM, Franklin G, Plaeger-Brockway R, Mootz RD. Improving the quality of workers' compensation health care delivery: The Washington State Occupational Health Services Project. The Milbank Quarterly 79:5-33, 2001.
  69. Kyes KB, Wickizer TM, Franklin G. Two-year health and employment outcomes among injured workers enrolled in the Washington State Managed Care Pilot Project. Amer J Ind Med 40:619-626, 2001.
  70. Farin FM, Janssen P, Quigley S, Abbott D, Hassett C, Smith-Weller T, Franklin GM, Swanson PD, Longstreth Jr WT, Omiecinski CJ, Checkoway H. Genetic polymorphisms of microsomal and soluble epoxide hydrolase and risk of parkinson’s disease. Pharmacogenetics 11:703-708, 2001.
  71. Battie MC, Fulton-Kehoe D, Franklin GM. The effects of a medical care utilization review program on back and neck injury claims. J Occup Environ Med 44:365-371, 2002.
  72. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155:732-738, 2002.
  73. Jarvik JG, Yuen E, Haynor DR, Bradley CM, Fulton-Kehoe D, Smith-Weller T, Wu R, Kliot M, Kraft G, Wang L, Robinson L, Erlich V, Franklin GM. MR Nerve Imaging in a prospective cohort of patients with suspected carpal tunnel syndrome. Neurology 58:1597-1602, 2002.
  74. Wickizer TM, Franklin G, Plaeger-Brockway R, Mootz R, Drylie D. Improving the quality of occupational health care in Washington State: new approaches to designing community-based health care systems. J Ambul Care Manage 25:43-52, 2002.
  75. Franklin GM and Zahn CA. AAN clinical practice guidelines: Above the fray (editorial). Neurology 59:975-976, 2002.
  76. Daniell WE, Fulton-Kehoe D, Cohen M, Swan S, Franklin GM. Increased reporting of occupational hearing loss: Workers’ compensation in Washington State, 1984-1988. Am J Ind Med 42:502-510, 2002.
  77. Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotyp Parkinson’s disease. Neurotoxicology 23:515-519, 2002.
  78. Kyes KB, Wickizer TM, Franklin GM. Employer satisfaction with workers’ compensation health care: Results of the Washington State workers’ compensation managed care program. J Occup Environ Med 45:234-240, 2003.
  79. Powers KM, Smith-Weller T, Franklin GM, Longstreth, Jr., WT, Swanson PD, Checkoway H. Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60:1761-1766, 2003.
  80. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett 337:5-8, 2003.
  81. Turner JA, Fulton-Kehoe D, Franklin G, Wickizer TM, Wu R. Comparison of the Roland-Morris Disability Questionnaire and generic health status measures: a population-based study of workers’ compensation back injury claimants. Spine 28:1061-1067, 2003.
  82. Kelada SN, Costa-Mallen P, Checkoway H, Viernes HA, Farin FM, Smith-Weller T, Franklin GM, Costa LG, Longstreth WT Jr, Furlong CE, Jarvik GP, Swanson PD. Paraoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:546-547, 2003.
  83. Franklin GM and Nelson L. Environmental risk factors in multiple sclerosis: Causes, triggers, and patient autonomy. Editorial. Neurology 61:1032-1034, 2003.
  84. Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT Jr, Viernes HM, Farin FMk, Smith-Weller T, Checkoway H. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson’s disease cases and unrelated controls. Mov Disord 19:76-83.
  85. Wickizer TM, Kopjar B, Franklin GM, Joesch J. Do drug-free workplace programs prevent occupational injuries? Evidence from Washington State. Health Serv Res 39:85-105, 2004.
  86. Wickizer TM, Franklin GM, Turner JA, Fulton-Kehoe D, Mootz R. Smith-Weller T. Use of attorneys in appeal filing in the Washington State workers’ compensation program: Does patient satisfaction matter? J Occup Environ Med 46:331-339; 2004.
  87. Wickizer TM, Franklin G, Fulton-Kehoe D, Turner JA, Mootz R, Smith-Weller T. Patient satisfaction, treatment experience and disability outcomes in a population-based cohort of injured workers in Washington State: Implications for quality improvement. Health Serv Res 39:727-748, 2004.
  88. Franklin GM, Wickizer TM, Fulton-Kehoe D, Turner JA. Policy-relevant research: When does it matter? NeuroRx 1:356-362, 2004.
  89. Wickizer TM, Franklin GM, Mootz RD, Fulton-Kehoe D, Plaeger-Brockway R, Drylie D, Turner JA, Smith-Weller T. A communitywide intervention to improve outcomes and reduce disability among injured workers in Washington State. Milbank Quarterly 82:547-567, 2004.
  90. Turner JA, Franklin G, Heagerty PJ, Wu R, Egan K, Fulton-Kehoe D, Gluck JV, Wickizer TM. The association between pain and disability. Pain 112:307-314, 2004.
  91. Wickizer TM, Franklin G, Gluck JV, Fulton-Kehoe D. Improving quality through identifying inappropriate care: the use of guideline-based utilization review protocols in the Washington State Workers’ Compensation System. J occup Environ Med 46:198-204, 2004.
  92. Turner JA, Franklin G, Fulton-Kehoe D, Egan K, Wickizer TM, Lymp JF, Sheppard L, Kaufman JD. Prediction of chronic disability in work-related musculoskeletal disorders: a prospective, population-based study. BMC Musculoskeletal Disord 5:14, 2004.
  93. Robinson JP, Fulton-Kehoe D, Franklin GM, Wu R. Multidisciplinary pain center outcomes in Washington State Workers’ Compensation. J Occup Environ Med 46:473-8, 2004.
  94. Okada S, Farin FM, Stapleton P, Viernes H, Quigley SD, Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. No associations between Parkinson’s disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes. Neuroscience Letters 375:178-80, 2005.
  95. Storm S, Beaver SK, Giardino N, Kliot M, Franklin GM, Jarvik JG, Chan L. Compliance with electrodiagnostic guidelines for patients undergoing carpal tunnel release.  Arch Phys Med Rehabil 86:8-11, 2005.
  96. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L. Opioid dosing trends and mortality in Washington State workers’ compensation, 1996-2002. Am J Ind Med 48:91-99, 2005.
  97. Kelada SN, Costa-Mallen P, Checkoway H, Carlson CS, Weller TS, Swanson PD, Franklin GM, Longstreth WT Jr, Afsharinejad Z, Costa LG. Dopamine transporter (SLC6A3) 5 region haplotypes significantly affect transcriptional activity but are not associated with Parkinson’s disease. Pharmacogenet Genomics 15:659-668, 2005.
  98. Daniell WE, Fulton-Kehoe D, Chiou LA, Franklin GM. Work-related carpal tunnel syndrome in Washington State workers’ compensation: temporal trends, clinical practices, and disability. Am J Ind Med 48:259-269, 2005.
  99. England JD, Gronseth GS, Franklin G, et al.  Distal symmetrical polyneuropathy. A definition for clinical research. Neurology  64: 199-207, 2005.
  100. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanon PD, Checkoway H. Diabetes, smoking, and other medical conditions in relation to Parkinson’s disease risk. Parkinsonism Relat Disord 12:185-189, 2006.
  101. Ton TG, Heckbert SR, Longstreth WT Jr, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Nonsteroidal anti-inflammatory drugs and risk of Parkinson’s disease. Mov Disord 21:964-969, 2006.
  102. Turner JA, Franklin G, Fulton-Kehoe D, Sheppard L, Wickizer TM, Wu R, Gluck JV, Egan K. Worker recovery expectations and fear-avoidance predict work disability in a population-based workers’ compensation back pain sample. Spine 31:682-689, 2006.
  103. Kelada SNP, Checkoway H, Kardia SLR, Carlson CS, Costa-Mallen P, Eaton DL, Firestone J, Powers KM, Swanson PD, Franklin GM, Longstreth, WT Jr, Smith-Weller T, Afsharinejad A, Costa L. 5 and 3 region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson’s disease risk: a hypothesis-generating study. Hum Mol Genet 15:3055-3062, 2006.
  104. Stover BD, Turner JA, Franklin G, Gluck JV, Fulton-Kehoe D, Sheppard L, Wickizer TM, Kaufman J, Egan K. Factors associated with early opioid prescription among workers with low back injuries. J Pain 7:718-725, 2006.
  105. Juratli S, Franklin GM, Mirza SK, Wickizer TM, Fulton-Kehoe D. Lumbar fusion outcomes in Washington State workers’ compensation. Spine 31:2715-2723, 2006.
  106. Stover B, Wickizer TM, Zimmerman F, Fulton-Kehoe D, Franklin G. Prognostic factors of long-term disability in a workers’ compensation system. J Occup Environ Med 49:31-40, 2007.
  107. Ton TG, Heckbert SR, Longstreth Jr WT, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Calcium channel blockers and beta-blockers in relation to Parkinson’s disease. Parkinsonism Relat Disord 13:165-169, 2007.
  108. Fulton-Kehoe D, Gluck J, Wu R, Mootz R, Wickizer TM, Franklin GM. Measuring work disability: What can administrative data tell us about patient outcomes? J Occup Environ Med 49:651-658, 2007.
  109. Turner JA, Franklin G, Fulton-Kehoe D, Sheppard L, Wickizer TM, Wu R, Gluck JV, Egan K, Stover B. Early predictors of chronic work disability associated with carpal tunnel syndrome: a longitudinal workers’ compensation cohort study. Am J Ind Med 50:489-500, 2007.
  110. Sears JM, Wickizer TM, Franklin GM, Cheadle AD,Berkowitz B. Nurse practitioners as attending providers for workers with uncomplicated back injuries: Using administrative data to evaluate quality and process of care. J Occup Environ Med 49:900-908, 2007.
  111. Sears JM, Wickizer TM, Franklin GM, Cheadle AD, Berkowitz B. Nurse practitioners as attending providers for injured workers: Evaluating the effect of role expansion on disability and costs. Med Care 45:1154-1161, 2007.
  112. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM. Early opioid prescription and subsequent disability among workers with back injuries: The Disability Risk Identification Study Cohort. Spine 33:199-204, 2008.
  113. Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC. Invited article: Neurology and quality improvement–An introduction. Neurology 70:1636-1640, 2008.
  114. Costa-Mallen P, Checkoway H, Zabeti A, Edenfield MJ, Swanson PD, Longstreth WT, Franklin GM, Smith-Weller T, Sadrzadehl SMH. The functional polymorphism of the hemoglobin-binding haptoglobin influences susceptibility to idiopathic Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet 147B:216-222, 2008.
  115. Sears JM, Wickizer TM, Franklin GM, Cheadle AD, Berkowitz B. Expanding the role of nurse practitioners: effects on rural access to care for injured workers. J Rural Health 24:171-178, 2008.
  116. Fulton-Kehoe D, Stover B, Turner JA, Sheppard L, Gluck J, Wickizer T, Franklin GM. Development of a brief questionnaire to predict long-term disability. J Occup Environ Med 50:1042-1052, 2008.
  117. Jarvik HG, Comstock BA, Heagerty PJ, Haynor DR, Fulton-Kehoe D, Kliot M, Franklin GM. Magnetic resonance imaging compared with electrodiagnostic studies in patients with suspected carpal tunnel syndrome: predicting symptoms, function and surgical benefit at 1 year. J Neurosurg 108:541-550, 2008.
  118. Sears JM, Wickizer TM, Franklin GM. Overstating the prevalence of symptom exaggeration in workers’ compensation cases. J Hand Surg Am 33:1014-1015, 2008.
  119. Turner JA, Franklin G, Fulton-Kehoe D, Sheppard L, Stover B, Wu R, Gluck JV, Wickizer TM. ISSLS prize winner: Early predictors of chronic work disability: A prospective, population-based study of workers with back injuries. Spine 33:2809-2818, 2008.
  120. Juratli SM, Mirza SK, Fulton-Kehoe D, Wickizer TM, Franklin GM. Mortality after lumbar fusion surgery. Spine 34:740-747, 2009.
  121. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanon PD, Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinson’s disease. Parkinsonism Rel Disord 15:47-52, 2009.
  122. Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D. Opioid use for chronic back pain: A prospective, population-based study among injured workers in Washington State, 2002-2005. Clin J Pain 25:743-751, 2009.
  123. Franklin GM, Budenholzer BR. Implementing evidence-based health policy in Washington State. N Engl J Med 361:18, 2009.
  124. Franklin GM and Tremlett H. Multiple sclerosis and pregnancy. What should we be telling our patients? Neurology 73:1820-1822, 2009.
  125. Daniell WE, Fulton-Kehoe D, Franklin GM. Work-related carpal tunnel syndrome in Washington State workers’ compensation: utilization of surgery and the duration of lost work. Am J Ind Med 52:931-942, 2009.
  126. Firestone JA, Lundin JI, Powers KM, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H. Occupational factors and risk of Parkinson’s disease: A population-based case-control study. Am J Ind Med 53: 217-23, 2010.
  127. Juratli SM, Nayan M, Fulton-Kehoe D, Robinson LR, Franklin GM. A population-based study of ulnar neuropathy at the elbow in Washington State workers’ compensation. Am J Ind Med  53: 1242-51, 2010.
  128. Bever CT, Franklin GM, Kaufman JM, Esper GJ. Role of professionalism in improving the patient-centeredness, timeliness, and equity of neurological care. Arch Neurol  67: 1386-90, 2010.
  129. England JD, Franklin GM. Automated hand-held devices: Raw data, raw interpretations. Muscle & Nerve 43: 6-8, 2011.
  130. Wickizer TM, Franklin G, Fulton-Kehoe D, Gluck J, Mootz R, Smith-Weller T, Plaeger-Brockway R. Improving quality, preventing disability and reducing costs in workers’ compensation healthcare: A population-based intervention study. Med Care 49:1105-11, 2011.
  131. Searles Nielsen S, Gallagher LG, Lundin JI, Longstreth WT Jr, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Environmental tobacco smoke and Parkinson’s disease. Mov Disord 2011 Nov 16 (Epub ahead of print).
  132. Graves JM, Fulton-Kehoe D, Martin DP, Jarvik JG, Franklin GM. Factors associated with early MRI utilization for acute occupational low back pain: A population-based study from Washington State workers compensation. Spine 2011 Oct 24 [Epub ahead of print].
  133. Morse JS, Stockbridge H, Egan KB, Mai J, Wickizer T, Franklin GM. Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline. J Opioid Manag 7:427-33, 2011.
  134. Franklin GM, Mai J, Turner, J, Sullivan, M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: Impact of the Washington State Opioid Dosing Guideline. Am J Ind Med 2011 Dec 27 [Epub ahead of print].
  135. Graves JM, Fulton-Kehoe D, Jarvik JG, Franklin GM. Early imaging for acute low back pain: One-year health and disability outcomes among Washington State workers. Spine 2012 Mar 13 [Epub ahead of print].
  136. Spector JT, Turner JA, Fulton-Kehoe D, Franklin G. Pre-surgery disability compensation predicts long-term disability among workers with carpal tunnel syndrome. Am J Ind Med 2012 Mar 5 [Epub ahead of print].

EVIDENCE-BASED PRACTICE GUIDELINES PUBLISHED IN PEER REVIEWED JOURNALS

  1. Diabetic Neuropathy Consensus Panel. Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Ann Neurol 1988; 24:99-104.
  2. The following practice advisories and practice parameters are reports of the Quality Standards Subcommittee of the American Academy of Neurology:

  3. Lumbar puncture. Neurology 1993; 43:625-627.
  4. Initial therapy of Parkinson’s Disease. Neurology 1993; 43:1296-1297.
  5. Electrodiagnostic studies in carpal tunnel syndrome. Neurology 1993; 43:2406-2409.
  6. Magnetic resonance imaging in the evaluation of low back syndrome. Neurology 1994; 44:767-770.
  7. The utility of neuroimaging in the evaluation of headache in patients with normal neurological evaluation. Neurology 1994; 44:1353-1354.
  8. Practice advisory (Facilitator: GM Franklin): An advisory on the use of Betaseron in multiple sclerosis. Neurology 1994; 44:1537-1540.
  9. Diagnosis and evaluation of dementia. Neurology 1994; 44:2203-2206.
  10. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995; 45:585-587.
  11. Determining brain death in adults. Neurology 1995; 45:1012-1014.
  12. Assessment and management of patients in the persistent vegetative state. Neurology 1995; 45:1015-1018.
  13. Electroencephalogram in the evaluation of headache. Neurology 1995; 45:1411-1413.
  14. Diagnosis of patients with nervous system Lyme borreliosis (Lyme disease): summary statement. Neurology 1996; 46:881-882.
  15. Neuroimaging in the emergency patient presenting with seizure: summary statement. Neurology 1996; 47:288-291.
  16. A guideline for discontinuing antiepileptic drugs in seizure-free patients: summary statement. Neurology 1996; 47:600-602.
  17. Thrombolytic therapy for acute ischemic stroke: summary statement. Neurology 1996; 47:835-839.
  18. Management of concussion in sports: summary statement. Neurology 1997; 48:581-585.
  19. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole. Neurology 1997; 49:657-659.
  20. Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998, 50:21-26.
  21. Stroke prevention in patients with nonvalvular atrial fibrillation. Neurology 1998; 51:671-673.
  22. Management issues for women with epilepsy. Neurology 1998; 51:944-948.
  23. Electrodiagnostic studies in ulnar neuropathy at the elbow. Neurology 1999; 52:588-690.
  24. Care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Neurology 1999; 52:1311-1323.
  25. Practice advisory: The use of Felbamate in the treatment of patients with intractable epilepsy. Neurology 1999; 52:1540-1545.
  26. Evidence-based guidelines for migraine headache: overview of program description and methodology. Online at http://www.aan.com; posted 4/25/00.
  27. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. Online at http://www.aan.com; posted 4/25/00.
  28. Evidence-based guidelines for migraine headache in the primary care setting: neuroimaging in patients with acute headache. Online at http://www.aan.com; posted 4/25/00.
  29. Evidence-based guidelines for migraine headache in the primary care setting: behavioral and physical treatments. Online at http://www.aan.com; posted 4/25/00.
  30. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Online at http://www.aan.com; posted 4/25/00.
  31. The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis. Neurology 2000; 54:1720-1725.
  32. Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 2000; 54:1886-1893.
  33. The role of corticosteroids in the management of acute monosymptomatic optic neuritis. Neurology 2000; 54:2039-2044.
  34. Risk of driving and Alzheimer’s disease. Neurology 2000; 54:2205-2211.
  35. Thymectomy for autoimmune myasthenia gravis. Neurology 2000; 55:7-15.
  36. Screening and diagnosis of autism. Neurology 2000; 55:468-479.
  37. Evaluating a first nonfebrile seizure in children. Neurology 2000; 55:616-623.
  38. Evidence-based guidelines for migraine headache (an evidence-based review). Neurology 2000; 55:754-763.
  39. Steroids, acyclovir, and surgery for Bell’s palsy (an evidence-based review). Neurology 2001; 56:830-836.
  40. Early detection of dementia: Mild cognitive impairment (an evidence-based review). Neurology 2001 56:1133-1142.
  41. Diagnosis of dementia (an evidence-based review). Neurology 2001; 56:1154-1166.
  42. Management of dementia (an evidence-based review). Neurology 2001; 56:1154-1166.
  43. Initiation of treatment for Parkinson’s disease: an evidence based review. Neurology 2002; 58:11-17.
  44. American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medical Rehabilitation. Practice parameter for electrodiagnosis studies in carpal tunnel syndrome: Summary statement. Muscle Nerve 2002, 25:918-922.
  45. Anticonvulsant drug prophylaxis in patients with severe traumatic brain injury. Neurology 2003; 60:10-16.
  46. Treatment of the child with a first nonprovoked seizure. Neurology 2003, 60:166-175.
  47. Evaluation of the child with global development delay. Neurology 2003, 60:367-380.
  48. Efficacy of mesial temporal and localized neocortical resections for epilepsy. Neurology 2003, 60: 538-547.
  49. Immunotherapy for Guillain-Barre Syndrome. Neurology 2003, 61:736-740.
  50. Diagnostic assessment of the child with cerebral palsy. Neurology 2004, 62:851-863.
  51. Treatment of postherpetic neuralgia. Neurology 2004, 62:959-965.
  52. Recurrent stroke with patent foramen ovale and atrial septal aneurysm. Neurology 2004, 62:1042-1050.
  53. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Neurology 2004, 62:1252-1260.
  54. Report: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 2004, 62:1261-1273.
  55. Medical treatment of infantile spasms. Neurology 2004, 62:1668-1681.
  56. Treatment of migraine headache in children and adolescents. Neurology 2004, 63:2215-2224.
  57. Corticosteroid treatment of Duchenne dystrophy. Neurology 2005, 64:13-20.
  58. Therapies for essential tremor. Neurology 2005, 64:2008-2020.
  59. Diagnosis and prognosis of new onset Parkinson disease. Neurology 2006, 66:968-975.
  60. Neuroprotective strategies and alternative therapies for Parkinson disease. Neurology 2006, 66:976-982.
  61. Treatment of Parkinson disease with motor fluctuation and dyskinesia. Neurology 2006, 66:983-995.
  62. Evaluation and treatment of depression, psychosis and dementia in Parkinson disease. Neurology 2006, 66:996-1002.
  63. Prediction of outcome in comatose survivors after cardiopulmonary resuscitation. Neurology 2006, 67:203-210.
  64. Diagnostic assessment of the child with status epilepitcus. Neurology 2006, 67:1542-1550.
  65. The medical treatment of ocular myasthenia (an evidence-based review). Neurology 2007, 68:1-6.
  66. Treatment of nervous system Lyme disease. Neurology 2007, 69:1.
  67. Treatment of painful diabetic neuropathy. Neurology 2011, 76: 1758-65.
  68. International collaboration in the use of registries for new devices and procedures. B. Campbell and H. Patrick on behalf of the REGISTER Group. Br J Surg 2012. DOI: 10.1002/bjs.8791.

ABSTRACTS

  1. Franklin GM, Diamond I. The relationship of acetylcholine synthesis at the neuromuscular junction to changes in muscle mass and function. Neurology 23:435, 1973.
  2. Franklin GM, Diamond I. The relationship of acetylcholine synthesis at the neuromuscular junction to changes in muscle mass and function. Ped. Research 7:420, 1973.
  3. Franklin GM, Dudzinski DS, Cutler RWP. Regulation of spinal fluid glycine concentration in the rat. Neurology 24:371, 1974.
  4. Minnich JS, Cruz M, Franklin GM. Ouabain induced seizures:  Decreased free amino acids in cerebellum. Trans Am Soc Neurochem 1976.
  5. Franklin GM, Baskin F, Rosenberg RN. High affinity uptake of taurine into clonal mouse neuroblastoma cell lines. Trans Am Soc Neurochem 1976.
  6. Thompson DS, Nelson LM, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis:  A retrospective study. Neurology 34:244, 1984.
  7. Franklin GM, Boteler D, Nelson L. Occupational carpal tunnel syndrome in an Oregon neurology practice. Am J Epidemiol 120:493, 1984.
  8. Franklin GM, Ulibarri VF, Nelson LM, DeLapp HC, Ringel SP. Neurology practice patterns in Colorado. Neurology 35(Suppl.1):278, 1985.
  9. Robertson RP, Murphy D, Franklin GM, Wangaard C, Nelson LM. Effect of cyclosporine on insulin-secretion invitro and in nondiabetic human subjects. Clin Res 33:A851, 1985.
  10. Ringel SP, Franklin GM, DeLapp HC, Ford P, Piner K, Stetler D. Prospective study of neurology practice patterns in Colorado. Neurology 36(Suppl.1):165, 1986.
  11. Franklin GM, Heaton RK, Filley CM, Seibert CE, Nelson LM. Correlation of neuropsychological and magnetic resonance imaging (MRI) findings in chronic/progressive multiple sclerosis. Neurology 36(Suppl.1):185, 1986.
  12. Ringel SP, Franklin GM, DeLapp C, Ford P. Neurology practice patterns:  comparison of academic and private practicing neurologists. Neurology 37:192, 1987.
  13. Nelson LM and Franklin GM. Risk of multiple sclerosis exacerbation during pregnancy and breastfeeding. Neurology 37:299, 1987.
  14. Kerman RH, Wolinsky JS, Nath A, Sears ES, Franklin GM, Nelson LM. Immune regulation in multiple sclerosis patients treated with cyclosporine. Ann Neurol 22:154, 1987.
  15. Franklin GM, Hamman RF, Baxter J, Kahn L. An epidemiologic study of neuropathy in the San Luis Valley, Colorado. Am J Epidemiol 126:750, 1987.
  16. The Multiple Sclerosis Study Group. The efficacy of cyclosporine immunosuppression in multiple sclerosis:  A preliminary report of a randomized, placebo-controlled clinical trial. Ann Neurol 24:169, 1988.
  17. The Multiple Sclerosis Study Group. The toxicity of cyclosporine immunosuppression in multiple sclerosis:  Preliminary analysis of a randomized, placebo-controlled clinical trial. Ann Neurol 24:169, 1988.
  18. The Multiple Sclerosis Study Group. Measuring disease status in chronic progressive multiple sclerosis:  Should a unified rating scale be used?  Ann Neurol 24:144, 1988.
  19. Brar SP, Smith MB, Nelson LM, Cobble ND, Franklin GM. Effect and management of multiple sclerosis spasticity–physical versus medical intervention. Arch Phys Med Rehabil 69:772, 1988.
  20. Cohen JA, Hossack K, Franklin GM, Herrera W, Burks J. Autonomic nervous system (ANS) dysfunction is associated with decreased exercize capacity in multiple sclerosis (MS) patients. Neurology 39(suppl.1):145, 1989.
  21. Franklin, G.M., Ringel, S.P., and Jones, M. A prospective study of principal care among Colorado neurologists. Neurology 39(suppl.1): 286, 1989.
  22. Franklin GM, Haug JA, Peck NB, Heyer N, Checkoway H. Occupational carpal tunnel syndrome in Washington State, 1984-1987. Neurology 40(suppl.1):429, 1990.
  23. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Neuropathy risk-factors in non-insulin-dependent diabetes-mellitus (NIDDM)–the San-Luis-Valley Diabetes Study. Am J Epidemiol 132:806, 1990.
  24. Franklin GM, McKeefrey S, Haug J, Picciano JA. A population-based study of lumbar fusion for non-traumatic occupational low back pain in Washington State, 1986-1988. Neurology; 41(suppl.1):165, 1991.
  25. Franklin, GM. and Heyer N.J. Occupational morbid brain injury in Washington State, 1988-1990. Neurology; 42(supp 3):193,1991.
  26. Haug, J.A., Franklin, GM, Wagner, E, Gilmore TM. Clinical and functional outcomes of carpal tunnel surgery in a population-based cohort. Neurology; 42(suppl.3): 269, 1992.
  27. Franklin GM, Cheadle A, Wolfhagen C, Savarino J, Liu PY, Salley C, Weaver M. Factors influencing duration of work-related disability: a population-based study from Washington workers’ compensation. Neurology 43(suppl.3):331, 1993.
  28. Franklin GM, Fulton-Kehoe D, Smith-Weller T. Outcome of surgery for thoracic outlet syndrome in Washington workers’ compensation, 1986-1991. Neurology 44(suppl.2):380, 1994.
  29. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence and risk factors for distal symmetrical neuropathy (DSN) in non-insulin-dependent diabetes mellitus (NIDDM)–The San Luis Valley Diabetes Study. Am J Epidemiol 139:S80, 1994.
  30. Longstreth WT, Franklin GM. Interferon-beta treatment of multiple-sclerosis. Neurology 44:187, 1994.
  31. Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Neurologist agreement on potential cases of Parkinson’s disease identified for case-control study. Neurology 45, 1995.
  32. Fulton-Kehoe D, Franklin GM. The burden of disability from carpal tunnel syndrome in Washington state workers’ compensation. Neurology 45(suppl.2), 1995.
  33. Franklin GM, Pace S, Love LA. Acute neurologic events associated with ingestion of Ma Huang (Ephedra). Neurology 47(suppl.2):282, 1996.
  34. Franklin GM, Checkoway H, Costa-Mallen P, Swanson PD, Smith-Weller T, Levy D, Costa LG. The “protective” effect of smoking in Parkinson’s disease is modified by an MAO-B polymorphism. Neurology 48(suppl.3):334-335, 1997.
  35. Robinson J., Fulton-Kehoe D, Franklin GM. Outcome of pain center treatment in Washington workers’ compensation, 1991-1993. Neurology 48(suppl.3):346-347, 1997.
  36. Franklin GM, Anderson C, Checkoway H, Beresford S, Smith-Weller T, Swanson P. An incident case-control study of dietary factors in Parkinson’s disease. Neurology 50(suppl.4):S60005, 1998.
  37. Daniell WE, Fulton-Kehoe D, Bradley CM, Franklin GM. Occupational carpal tunnel syndrome in Washington State, 1986-1994. Neurology, 50:S01008, 1998.
  38. Franklin GM, Jarvik JG, Bradley C, Kraft G, Fulton-Kehoe D, Haynor D, Kliot, M, Smith-Weller T, Yuen E. Magnetic resonance neurography (MRN): a prospective study of persons with suspected carpal tunnel syndrome. Neurology 52(suppl.2):A89, 1999.
  39. Daniell WE, Fulton-Kehoe D, Chiou LA, Franklin GM. Who gets carpal tunnel surgery? Predictive factors from a population-based study of Washington State workers’ compensation. Neurology 54(suppl.2):345-346, 2000.
  40. Firestone JA, Franklin GM, Longstreth WT, Smith-Weller T, Swanson PD, Checkoway H. residential pesticide exposure and risk of Parkinson’s disease. Epidemiol 13:799, 2002.
  41. Kelada SN, Costa-Mallen P, Checkoway H, Viernes HA, Farin FM, Smith-Weller T, Franklin GM, Cost LG, Longstreth WT, Furlong CE, Jarvik GP, Swanson PD. Paaoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease.

PAPERS PRESENTED AT PROFESSIONAL MEETINGS

  1.  Franklin GM, Diamond I. The relationship of acetylcholine synthesis at the neuromuscular junction to changes in muscle mass and function. 3rd International Congress of Muscle Diseases, Newcastle upon Tyne, England, September 1974.
  2.  Minnich JS, Cruz M, Franklin GM. Ouabain induced seizures:  Decreased free amino acids in cerebellum. American Society of Neurochemistry, Vancouver, BC, March 1976.
  3.  Franklin GM, Baskin F, Rosenberg RN. High affinity uptake of taurine into clonal mouse neuroblastoma cell lines. American Society of Neurochemistry, Vancouver, BC, March 1976.
  4. Franklin GM, Kirkpatrick JB. Panel:  Neurobiology of peripheral nerve. Winter Conference on Brain Research, Keystone, Colorado, January 1978.
  5. Franklin GM, Kirkpatrick JB. Panel:  Neurobiology of pain. Winter Conference on Brain Research, Keystone, Colorado, January 1978.
  6. Franklin GM, Kirkpatrick JB. Panel:  Learning disabilities:  Classification and structural basis. Winter Conference on Brain Research, Keystone, Colorado, January 1980.
  7. Franklin GM. Sugar, behavior and the brain. Presented at symposium, Nutrition and the Brain, Berkeley, California, October 17-18, 1981.
  8. Thompson DS, Nelson LM, Burks J.S, Franklin GM. The effects of pregnancy in multiple sclerosis (MS):  A retrospective study. American Academy of Neurology, Boston, April 1984.
  9. Nelson LM, Boteler D, Franklin GM. An MS referral center population:  Is it representative?  World Federation of Neurology - Section of Neuroepidemiology, Boston, April 1984.
  10. Franklin GM, Boteler D, Nelson LM. Occupational carpal tunnel syndrome in Oregon. Society for Epidemiologic Research, Houston, June 1984.
  11. Nelson LM, Hamman RF, Baum H, Thompson DS, Burks JS, Franklin GM. Higher than expected prevalence of multiple sclerosis (MS) in Northern Colorado. Society for Epidemiologic Research, Houston, June 1984.
  12. Franklin GM, Nelson LM, Heaton RK, Burks JS. Stress and its relationship to acute exacerbations in multiple sclerosis (MS):  A prospective study. Epidemiological Research Exchange, University of Colorado School of Medicine, October 1984.
  13. Franklin GM, Ulibarri VF, Nelson LM, DeLapp HC, Ringel SP. Neurology practice patterns in Colorado. American Academy of Neurology, Dallas, April 1985.
  14. Robertson RP, Murphy D, Franklin GM, Wangaard C, Nelson LM. Effect of cyclosporine on insulin secretion in vitro and in non-diabetic human subjects. Midwestern Section, American Federation for Clinical Research, Chicago, July 1985.
  15. Ringel SP, Franklin GM, DeLapp HC, Ford P, Piner K, Stetler D. Prospective study of neurology practice patterns in Colorado. American Academy of Neurology, New Orleans, April 1986.
  16. Franklin GM, Heaton RK, Filley CM, Seibert CE, Nelson LM. Correlation of neuropsychological and magnetic resonance imaging (MRI) findings in chronic/progressive multiple sclerosis. American Academy of Neurology, New Orleans, April 1986.
  17. Ringel SP, Franklin GM, DeLapp C, Ford P. Neurology practice patterns:  comparison of academic and private practicing neurologists. American Academy of Neurology, New York, April 1987.
  18. Nelson LM, Franklin GM. Risk of multiple sclerosis exacerbation during pregnancy and breastfeeding. American Academy of Neurology, New York, April 1987.
  19. Franklin GM, Kahn L, Baxter J, Hamman R. An epidemiologic study of neuropathy in the San Luis Valley, Colorado. Society for Epidemiologic Research, Amherst, MA, June 1987.
  20. Franklin GM, Nelson LM, Filley CM, Heaton RK. Early, severe cognitive loss in multiple sclerosis. American Academy of Neurology, Cincinnati, April, 1988.
  21. Franklin GM, Ringel SP, Jones M. A propspective study of principal care among Colorado neurologists. American Academy of Neurology, Chicago, April 1989.
  22. Franklin GM, Nelson LM, Jones M, Baron A. Prognostic factors in multiple sclerosis. World Federation of Neurology, Research Group on Neuroepidemiology, Chicago, April 1989.
  23. Franklin GM, Haug J A, Peck NB, Heyer N, Checkoway H. Occupational carpal tunnel syndrome in Washington State, 1984-1987. American Academy of Neurology, Miami, May 1990.
  24. Franklin GM, Shetterly S, Baxter J, Hamman RF. Risk factors for Neuropathy in non-insulin depenent diabetes mellitus:  the San Luis Valley Diabetes Study. The Society for Epidemiologic Research, Snowbird Utah, June 1990.
  25. Franklin GM, McKeefrey S, Haug J, Picciano J. A population-based study of lumbar fusion for non-traumatic occupational low back pain in Washington State, 1986-88. American Academy of Neurology, Boston, 1991.
  26. Franklin GM, Heyer NJ. Occupational morbid brain injury in Washington state, 1982-1990. American Academy of Neurology, San Diego, 1992.
  27. Haug JA, Franklin GM, Wagner E, Gilmore TM. Clinical and functional outcomes of carpal tunnel surgery in a population-based cohort. American Academy of Neurology, San Diego, 1992.
  28. Franklin GM, Cheadle A, Wolfhagen C, Savarino J, Liu PY, Salley C, Weaver M. Factors influencing duration of work-related disability: a population-based study from Washington workers’ compensation. American Academy of Neurology, New York, 1993.
  29. Checkoway H, Costa LG, Omiecinski C, Woods J, Franklin GM, Swanson P. Environmental and biochemical risk factors for Parkinson’s disease: The University of Washington Study. Parkinson’s Epidemiology Research Committee (PERC) Symposium, Santa Cruz, 1994.
  30. Fulton-Kehoe D, Franklin GM, Weaver M, Cheadle A. Productive years of life lost in Washington state workers’ compensation. American Public Health Association annual meeting, Washington, DC, 1994.
  31. Keyes K, Wickizer TM, Franklin G, Weaver M. Effects on quality and satisfaction of managed care in treating work-related injuries. American Public Health Association annual meeting, San Diego, October 1995.
  32. Keyes K, Wickizer TM, Franklin G, Weaver M. Effects on employer satisfaction of managed care in treating work-related injuries. American Public Health Association annual meeting, New York, November 1996.
  33. Keyes K, Wickizer TM, Franklin G. Final results of the Washington State Workers’ Compensation Managed Care Pilot Project. American Public Health Association annual meeting, Indianapolis, November 1997.
  34. Wickizer TM, Franklin G. New developments in disability prevention in Washington State. American Public Health Association annual meeting, Boston, November 2000.
  35. Wickizer TM, Kopjar B, Franklin G. The effectiveness of publicly sponsored drug-free workplace programs in reducing occupational injuries. Academy for Health Services Research and Health Policy annual meeting, Washington, DC, June 2002.
  36. Wickizer TM, Franklin G, Gluck J, Fulton-Kehoe D. Improving the efficiency and effectiveness of utilization management in identifying inappropriate care. Academy for Health Services Research and Health Policy annual meeting, Washington, DC, June 2002.
  37. Wickizer TM, Franklin G, Fulton-Kehoe D, Turner JA. Assessing patient satisfaction in relation to outcomes in a workers’ compensation system. Academy Health annual meeting, Nashville, June 2003.
  38. Wickizer TM, Franklin G. Improving the quality of care for injured workers in Washington State. American Public Health Association annual meeting, Washington, DC, November 2004.
  39. Wickizer TM, Franklin G, Fulton-Kehoe D. Reducing disability among injured workers in Washington State through quality improvement. American Public Health Association annual meeting, Philadelphia, December 2005.
  40. Sears JM, Wickizer TM, Franklin GM. Nurse practitioners as attending providers in a workers’ compensation system: Policy evaluation of recent legislation in Washington State. American Public Health Association annual meeting, Philadelphia PA, December 2005.
  41. Wickizer TM, Franklin G, Fulton-Kehoe D, Mootz R, Smith-Weller T, Plaeger-Brockway R, Drylie D. Design and implementation of workers’ compensation quality improvement in Washington State, in Research Colloquium on Workers’ Compensation Medical Benefit and Delivery and Return to Work, RAND Inc., Santa Monica, April 2006.
  42. Wickizer TM, Franklin G, Fulton-Kehoe D, Mootz R, Smith-Weller T. Improving the quality of care in workers’ compensation through a communitywide intervention: Did the IOM get it right? American Public Health Association annual meeting, Washington, DC, November 2007.
  43. Wickizer TM, Franklin G, Fulton-Kehoe D, Mootz R, Smith-Weller T. Can quality improvement of activities encourage physicians to adopt best practices in the delivery of care? Evidence from a quality improvement project in Washington State. American Public Health Association annual meeting, Washington, DC, November 2007.

BOOK CHAPTERS

  1. Franklin GM. Painful peripheral neuropathies. Proceedings of Eleventh Annual Winter Conference on Brain Research, pp. 87-89. Winter Conference on Brain Research, Keystone, Colorado, January 1978.
  2. Sears ES, Franklin GM. Diseases of the cranial nerves. In:  Neurology, ed. R.N. Rosenberg, Grune and Stratton, New York 1980.
  3. Franklin GM, Burks JS. Viral meningoencephalitis. In:  Conn's Current Therapy, ed. R.E. Rakel, WB Saunders Co., Philadelphia 1984.
  4. Franklin  GM, Burks, JS. Diagnosis and medical management of multiple sclerosis. In:  The Interdisciplinary Rehabilitation of Multiple Sclerosis and Muscular Disorders, eds. F.P. Maloney, J.S. Burks, and S.P. Ringel, Lippincott Publishers, Philadelphia 1985.
  5. Franklin GM, Nelson LM, Heaton RK, Filley CM. Dementia in multiple sclerosis - a clinical perspective. In:  The Neuropsychology of Multiple Sclerosis, ed. S. Rao, Oxford University Press 1990.
  6. Filley CM, Heaton RK, Thompson LL, Nelson LM, Franklin GM. Effects of disease course on neuropsychological functioning in multiple sclerosis. In:  The Neuropsychology of Multiple Sclerosis, ed. S. Rao, Oxford University Press 1990.
  7. Heaton RK, Thompson LL, Nelson LM, Filley CM, Franklin GM. Brief and intermediate length screening of neuropsychological impairment in multiple sclerosis. In:  The Neuropsychology of Multiple Sclerosis, ed. S. Rao, Oxford University Press 1990.
  8. Franklin GM, Nelson LM. Neurologic disorders. In: Chronic Disease Epidemiology, eds. R. Brownson and P. Remington, the American Public Health Association 1993.
  9. Franklin GM. Peripheral neuropathy. In: Handbook of Neuroepidemiology, eds. P. Gorelick and M. Alter, Marcel Dekker 1994.
  10. Franklin GM, Plaeger-Brockway R. Medical Practice Guidelines in Washington Workers’ Compensation. In: Review, Regulate, or Reform? What Works to Control Workers’ Compensation Medical Costs, ed. T.W. Grannemann, Workers Compensation Research Institute 1994.
  11. Franklin GM, Nelson LM. Neurologic disorders. In: Chronic Disease Epidemiology, second edition, eds. R. Brownson and P. Remington, the American Public Health Association 1997.
  12. Greenberg MK, Franklin GM. Practice parameters. In: Diagnostic Testing in Neurology, ed. R.W. Evans, WB Saunders Company 1999.
  13. Franklin GM. Carpal tunnel syndrome. Continuum 7:12-31, 2001.
  14. Franklin GM. Peripheral neuropathy. In: Neuroepidemiology. From Principles to Practice, ed. LM nelson, CM Tanner, SK Van Den Eeden, VM McGuire, Oxford University Press, 2004.
  15. Franklin GM, Turner JA, Wickizer TM, Fulton-Kehoe D, Mootz RD. Disability prevention. In: Schmidt RF, Willis WD, eds, Encyclopedia of Pain. Berlin: Springer-Verlag, pt 4, pp. 628-631, 2007.
  16. Franklin GM. Workers’ compensation issues in Thoracic Outlet Syndrome, in press, in Thompson R et al, Eds. Thoracic Outlet Syndrome, 2012
Review date: 
7/2/2009